These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2032589)

  • 1. Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea.
    Yamaguchi M; Aono T; Koike K; Nishikawa Y; Ikegami H; Miyake A; Tanizawa O
    Eur J Obstet Gynecol Reprod Biol; 1991 May; 39(3):187-91. PubMed ID: 2032589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult hyperprolactinemia in infertile women.
    Asukai K; Uemura T; Minaguchi H
    Fertil Steril; 1993 Sep; 60(3):423-7. PubMed ID: 8375520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone.
    Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
    Horm Res; 1989; 31(4):169-74. PubMed ID: 2507435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin secretion and corpus luteum function in women with luteal phase deficiency.
    Soules MR; Bremner WJ; Steiner RA; Clifton DK
    J Clin Endocrinol Metab; 1991 May; 72(5):986-92. PubMed ID: 2022718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on pathogenesis and treatment of normoprolactinemic galactorrhea syndrome].
    Aisaka K; Ando S; Kokubo K; Sasaki S; Sudo I; Toriya Y; Yoshida K; Mori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2385-92. PubMed ID: 4078422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
    Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
    J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
    Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperprolactinemic luteal insufficiency with bromocriptine.
    Andersen AN; Larsen JF; Eskildsen PC; Knoth M; Micic S; Svenstrup B; Nielsen J
    Acta Obstet Gynecol Scand; 1979; 58(4):379-83. PubMed ID: 525272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of drug-induced hyper- and hypoprolactinemia on human corpus luteum.
    Garcea N; Campo S; Siccardi P; Panetta V; Venneri M; Dargenio R
    Acta Eur Fertil; 1983; 14(1):35-40. PubMed ID: 6326451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of transient or occult hyperprolactinemia on luteal function].
    Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):117-25. PubMed ID: 3084307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
    Oseko F; Morikawa K; Motohashi T; Aso T
    Obstet Gynecol; 1988 Aug; 72(2):267-71. PubMed ID: 3134632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin in the evaluation of luteal phase in infertility.
    Vanrell JA; Balasch J
    Fertil Steril; 1983 Jan; 39(1):30-3. PubMed ID: 6848391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteal phase deficiency: abnormal gonadotropin and progesterone secretion patterns.
    Soules MR; Clifton DK; Cohen NL; Bremner WJ; Steiner RA
    J Clin Endocrinol Metab; 1989 Oct; 69(4):813-20. PubMed ID: 2506215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metoclopramide-induced hyperprolactinemia during early follicular development on human ovarian function.
    Kauppila A; Kirkinen P; Orava M; Vihko R
    J Clin Endocrinol Metab; 1984 Nov; 59(5):875-81. PubMed ID: 6384260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatographic pattern of circulating prolactin in ovulatory hyperprolactinemia.
    Andino NA; Bidot C; Valdés M; Machado AJ
    Fertil Steril; 1985 Nov; 44(5):600-5. PubMed ID: 3932101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteal phase hyperprolactinemia.
    Falk RJ; Anderson L
    Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between luteal function and prolactin in infertile women with endometriosis].
    Hayashi N; Taketani Y; Mizuno M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1720-4. PubMed ID: 2512358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of hyperprolactinemia determination within the scope of galactorrhea].
    Schurz B; Enzelsberger H; Kubista E; Wenzl R
    Zentralbl Gynakol; 1989; 111(1):33-8. PubMed ID: 2493708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential role of endogenous progesterone in modulation of GH, prolactin and thyrotrophin secretion during normal menstrual cycle.
    Caufriez A; Leproult R; L'Hermite-Balériaux M; Moreno-Reyes R; Copinschi G
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):535-42. PubMed ID: 19222493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gonadotrophin and sex steroid hormone levels during mid-follicular and mid-luteal phases in hyperprolactinaemic women with regular menstrual cycles.
    Nakano R
    Br J Obstet Gynaecol; 1987 Feb; 94(2):142-6. PubMed ID: 3103671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.